.jpeg "India–Oman CEPA to Boost Pharma Exports with Zero-Duty Access")
India–Oman CEPA to boost pharma exports with zero-duty access, faster approvals, and reduced compliance, unlocking growth opportunities in Oman’s pharma market.
Moderna and the Coalition for Epidemic Preparedness Innovations (CEPI) have joined forces to accelerate the development of a vaccine for the Bundibugyo strain of Ebola, marking a major step in global efforts to strengthen outbreak preparedness.
A late-stage clinical trial has shown that daraxonrasib, an experimental pancreatic cancer drug, significantly improved survival and disease control in patients with advanced cancer after chemotherapy failure.
.jpeg "Understanding Prostate Cancer: India's Growing Health Challenge")
Understanding prostate cancer in India, including rising cases, symptoms, risk factors, treatment options, cost, and how innovation and healthcare advancements are shaping outcomes.
As India and the United States begin a fresh round of trade negotiations in New Delhi from June 1 to June 4, the pharmaceutical sector has emerged as one of the most closely watched areas of discussion. The talks are expected to focus on tarif...
Zydus Lifesciences gains US FDA priority review for saroglitazar in PBC, strengthening its specialty pipeline amid rising global demand for liver disease therapies.
FDA inspection flags data integrity and manufacturing lapses at Dabur plant, raising compliance risks, export concerns, and quality scrutiny in the US market.
.jpeg "China's Biotech Boom Fuels $10.5B Pfizer Deal, Shows India Gap")
China’s biotech boom drives $10.5B Pfizer-Innovent deal, highlighting global shift to innovation while exposing India’s gaps in research, funding, and licensing.
Cipla targets 50 global filings, focusing on innovation, biosimilars, and complex generics to expand US and Europe presence and strengthen chronic therapy leadership.
Novo Nordisk’s Wegovy has received approval in India for teenagers struggling with obesity, opening a new treatment option for young patients aged 12 years and above. The approval of Novo Nordisk’s Wegovy in India for teens battling obesity come...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")